CHOICE OF THERAPEUTIC STRATEGY IN SEZARY SYNDROME: CASE REPORT
- Авторлар: Zaslavsky D.V1, Yunovidova A.A2, Wolkenstein P.3, Sydikov A.K1, Skrek S.V2,4, Kovalchuk A.K5, Sobolev A.V6, Salogub G.N7
-
Мекемелер:
- SPbSPMU
- NWSMU n.a. I.I. Mechnikov
- Dermatology Service of the Henri Mondor University Hospital
- French Clinic of Skin Diseases n.a. Pierre Wolkenstein
- Dermatovenerologic Dispensary №11 of the Central District of St. Petersburg
- SRI of Medical Mycology n.a. P.N. Kashkin NWSMU .a. I.I. Mechnikov
- FSPbSMU n.a. Acad. I.P. Pavlov
- Шығарылым: № 20 (2016)
- Беттер: 53-58
- Бөлім: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/289575
- ID: 289575
Дәйексөз келтіру
Аннотация
Негізгі сөздер
Толық мәтін
Авторлар туралы
D. Zaslavsky
SPbSPMUDepartment of dermatology
A. Yunovidova
NWSMU n.a. I.I. MechnikovDepartment of dermatology
P. Wolkenstein
Dermatology Service of the Henri Mondor University Hospital
A. Sydikov
SPbSPMUDepartment of dermatology
S. Skrek
NWSMU n.a. I.I. Mechnikov; French Clinic of Skin Diseases n.a. Pierre WolkensteinTeaching Assistant at the Department of Dermatovenerology
A. Kovalchuk
Dermatovenerologic Dispensary №11 of the Central District of St. Petersburg
A. Sobolev
SRI of Medical Mycology n.a. P.N. Kashkin NWSMU .a. I.I. Mechnikov
G. Salogub
FSPbSMU n.a. Acad. I.P. PavlovDepartment of Faculty Therapy with course of Endocrinology, Cardiology and Functional Diagnostics n.a. G.F. Lang with the Clinic
Әдебиет тізімі
- Scarisbrick J.J., Kim Y.H., Whittaker S.J., Wood G.S., Vermeer M.H., Prince H.M., Quagiino P. Prognostic factors, prognostic indices and staging in mycosis fungoides and Sézary syndrome: where are we now? Br. J. Dermatol. 2014;6:1226-36.
- Whittaker S.J., Marsden J.R., Spittle M., Jones R.R. Joint British Association of Dermatologists and U.K. Cutaneous Lymphoma Group guidelines for the management of primary cutaneous T-cell lymphomas. Br. J. Dermatol. 2003; 149:1095-107.
- Girardi M., Edelson R.L., Cutaneous T-Cell Lymphoma: Pathogenesis and Treatment. 0ncology.2000;14:1061-70.
- Trautingera F., Knoblera R., Willemzeb R., Perisc K., Stadlerd R., Larochee L., D'incanf M., Rankig A., Pimpinellih N., Ortiz-Romeroi P., Dummerj R., Estrachk T., Whittakerl S. EORTC consensus recommendations for the treatment of mycosis fungoides/Sezary syndrome. Eur. J. Cancer. 2006;42:1014-30.
- Olsen E.A., Rook A.H., Zic J., Kim Y., Porcu P., Querfeld C., Wood G., Demierre M.F., Pittelkow M., Wilson L.D., Pinter-Brown L., Advani R., Parker S., Kim E.J., Junkins-Hopkins J.M., Foss F., Cacchio P., Duvic M. Sézary syndrome: immunopathogenesis, literature review of therapeutic options, and recommendations for therapy by the United States Cutaneous Lymphoma Consortium (USCLC). J Am. Acad. Dermatol. 2011;64:352-404.
- Stadler R., Kremer A. Therapeutic advances in cutaneous T-cell lymphoma (CTCL): from retinoids to rexinoids. Semin. Oncol. 2006; 33:7-10.
- Ashworth J., Booker J., Breathnach S.M. Effects of topical corticosteroid therapy on Langerhans cell antigen presenting function in human skin. Br. J. Dermatol. 1988;118:457-70.
- Herrmann J.J., Roenigk H.H. Jr., Honigsmann H. Ultraviolet radiation for treatment of cutaneous T-cell lymphoma. Hematol. Oncol. Clin. North Am.1995;9:1077-88.
- Thomsen K., Hammar H., Molin L., Volden G. Retinoids plus PUVA (Re-PUVA) and PUVA in mycosis fungoides, plaque stage: a report from the Scandinavian mycosis fungoides group. Acta Derm. Venereol. 1989; 69:536-38.
- Lowe N.J., Cripps D.J., Dufton P.A., Vickers C.F Photochemotherapy for mycosis fungoides: a clinical and histological study. Arch. Dermatol. 1979;115:50-3.
- Mangelsdorf D.J., Umesono K., Evans R.M. The retinoid receptors. in: The Retinoids, Biology, Chemistry and Medicine. New York: Raven Press. 1994;2:319-50.
- Farooqui A.A., Antony P., Ong W.Y., Horrocks L.A., Freysz L. Retinoic acid-mediated phospholipase A2 signaling in the nucleus. Brain Res. Rev. 2004;45:179-95.
- Dunn L.K., Gaar L.R., Yentzer B.A., O'Neill J.L., Feldman S.R. Acitretin in dermatology: a review. J. Drugs Dermatol. 2011;10:772-82.
- Cheeley J., Sahn R.E., DeLong L.K., Parker S.R. Acitretin for the treatment of cutaneous T-cell lymphoma. J. Am. Acad. Dermatol. 2013;68:247-54.
- Sokoiowska-Wojdyto M., Lugowska-Umer H., Maciejewska-Radomska A. Oral retinoids and rexinoids in cutaneous T-cell lymphomas. Postepy Dermatol. Alergol. 2013;30:19-29.
- Ларина С.Н., Чебышев Н.В., Ших Е.В., Каркищенко В.Н. Модулирование действия ядерных рецепторов и регуляция биотрансформации веществ. Биомедицина. 2009;1:70-80.
- Beylot-Barry M. Bexarotène: Targretin. Ann. Dermatol. Venerol. 2007;134:987-91.
- Bagot M., Bensussan A. Les lymphomes T épidermotropes comme modèles de progression tumorale. Med. Sci. 2006;22:192-96.
- Bagot M. Les lymphomes cutanés. Paris: Springer, 2013. P 77-91.